Gyroscope Capital Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Gyroscope Capital Management Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$4.65M	Buy	80,036 +9,024	+13%	+$553K	1.07%	29
2023 Q2	$4.54M	Buy	71,012 +2,258	+3%	+$151K	1.05%	32
2023 Q1	$4.77M	Buy	68,754 +1,997	+3%	+$141K	1.21%	29
2022 Q4	$4.8M	Sell	66,757 -1,465	-2%	-$110K	1.46%	27
2022 Q3	$4.85M	Sell	68,222 -210	-0.3%	-$15.2K	1.87%	24
2022 Q2	$5.27M	Sell	68,432 -544	-0.8%	-$41.4K	1.81%	27
2022 Q1	$5.04M	Sell	68,976 -116,147	-63%	-$7.8M	1.73%	25
2021 Q4	$11.5M	Buy	185,123 +12,981	+8%	+$761K	4.06%	2
2021 Q3	$10.2M	Buy	172,142 +2,202	+1%	+$145K	3.85%	3
2021 Q2	$11.4M	Buy	169,940 +1,174	+0.7%	+$76.6K	3.99%	3
2021 Q1	$10.7M	Buy	168,766 +6,046	+4%	+$376K	4.26%	1
2020 Q4	$10.1M	Sell	162,720 -3,391	-2%	-$209K	4.34%	2
2020 Q3	$10M	Sell	166,111 -72,548	-30%	-$4.37M	4.54%	1
2020 Q2	$14M	Sell	238,659 -43,593	-15%	-$2.61M	6.37%	1
2020 Q1	$15.7M	Sell	282,252 -2,705	-0.9%	-$165K	7.4%	1
2019 Q4	$18.3M	Buy	284,957 +134,937	+90%	+$7.73M	6.6%	1
2019 Q3	$7.43M	Sell	150,020 -6,046	-4%	-$284K	2.95%	11
2019 Q2	$7.16M	Buy	156,066 +2,310	+2%	+$108K	2.7%	20
2019 Q1	$7.15M	Buy	153,756 +6,651	+5%	+$331K	2.73%	18
2018 Q4	$7.65M	Buy	+147,105	New	+$7.9M	2.92%	4

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Gyroscope Capital Management Group's BMY Position: Q3 2023 in Review

Gyroscope Capital Management Group increased its Bristol-Myers Squibb (BMY) stake by 13% in Q3 2023, buying an estimated $553K and bringing the position to 80,036 shares worth $4.65M. The position accounts for 1.07% of the portfolio, ranked #29.

Gyroscope Capital Management Group first reported a position in BMY in Q4 2018 and has held it in 20 quarters since. The position peaked at $18.3M in Q4 2019. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Gyroscope Capital Management Group held 80,036 shares of Bristol-Myers Squibb worth $4.65M as of Q3 2023.
Gyroscope Capital Management Group bought 9,024 Bristol-Myers Squibb shares in Q3 2023, an estimated $553K.
Bristol-Myers Squibb made up 1.07% of Gyroscope Capital Management Group's portfolio in Q3 2023, its #29 holding.
Gyroscope Capital Management Group first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 20 quarters since.
Gyroscope Capital Management Group's Bristol-Myers Squibb position peaked at $18.3M in Q4 2019.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Gyroscope Capital Management Group's 13F filing for Q3 2023, filed 13 Nov 2023.